{"id":"W2955483855","doi":"10.1007/s40744-019-0165-3","title":"Translating Improvements with Ixekizumab in Clinical Trial Outcomes into Clinical Practice: ASAS40, Pain, Fatigue, and Sleep in Ankylosing Spondylitis","year":2019,"lang":"en","type":"article","venue":"Rheumatology and Therapy","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; University Health Network","funders":"School of Medicine; University of Utah; Genentech; Celgene; Chugai Pharmaceutical; Amgen; Pfizer; Eli Lilly and Company; KU Leuven; U.S. Department of Veterans Affairs","keywords":"Ixekizumab; Medicine; Ankylosing spondylitis; Placebo; Physical therapy; Repeated measures design; Internal medicine; Clinical trial; Clinical endpoint; Secukinumab; Disease; Psoriatic arthritis; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001892509,0.0002330194,0.00107502,0.0001173414,0.00008035686,0.00001908809,0.00004749037,0.0002654375,0.00005415157],"category_scores_gemma":[0.0004874899,0.0001699942,0.00008596654,0.0001355808,0.0002166372,0.0001587481,0.00002748116,0.000440698,0.000003776993],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002376062,"about_ca_system_score_gemma":0.00006836083,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004636452,"about_ca_topic_score_gemma":0.0004247829,"domain_scores_codex":[0.9974078,0.0005552434,0.001025487,0.0005229234,0.0001550106,0.0003335374],"domain_scores_gemma":[0.997803,0.001605294,0.0002238273,0.0002167444,0.00004731489,0.0001038611],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02956848,0.0005858122,0.6696154,0.00003048175,0.0002852412,0.0001381938,0.0006502539,1.335876e-7,0.00000188399,0.0001902311,0.000004002282,0.2989298],"study_design_scores_gemma":[0.2537177,0.008419244,0.7329301,0.0003634496,0.00005568413,0.00019392,0.001140641,0.0001630787,0.000003959732,0.000405264,0.00236891,0.0002380407],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9883965,0.007571415,0.00002740639,0.002143914,0.0003254201,0.001229866,0.000005434274,0.0000230557,0.0002770028],"genre_scores_gemma":[0.9894413,0.007841414,0.001685794,0.0008915418,0.00002021495,0.00005177913,0.00002210469,0.00002272583,0.00002314847],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2986918,"threshold_uncertainty_score":0.6932163,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04098222901732711,"score_gpt":0.3942169106277126,"score_spread":0.3532346816103855,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}